First Manhattan Portfolio holdings
AUM
$35.4B
1-Year Return
24.51%
This Quarter Return
-15.95%
1 Year Return
+24.51%
3 Year Return
+86.41%
5 Year Return
+172.47%
10 Year Return
+337.52%
AUM
$24.8B
AUM Growth
-$5.76B
(-19%)
Cap. Flow
-$399M
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
58.6%
Holding
1,749
New
70
Increased
226
Reduced
442
Closed
86
Top Buys
| 1 |
FMC Excelsior Focus Equity ETF
FMCX
|
+$66.8M |
| 2 |
S&P Global
SPGI
|
+$52.3M |
| 3 |
Amazon
AMZN
|
+$19.7M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
+$19.1M |
| 5 |
Entegris
ENTG
|
+$14.2M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$150M |
| 2 |
GoDaddy
GDDY
|
+$63.2M |
| 3 |
Domino's
DPZ
|
+$37.2M |
| 4 |
IAA
IAA, Inc. Common Stock
IAA
|
+$33.2M |
| 5 |
PayPal
PYPL
|
+$32.3M |
Sector Composition
| 1 | Financials | 42.55% |
| 2 | Technology | 14.81% |
| 3 | Healthcare | 11.73% |
| 4 | Consumer Discretionary | 8.87% |
| 5 | Communication Services | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Lake Shore Bancorp
LSBK
$102M
| $259K | ﹤0.01% |
18,507
| – | – |
|
652
AstraZeneca
AZN
$251B
| $257K | ﹤0.01% |
3,900
| – | – |
|
653
Clearside Biomedical
CLSD
$27.4M
| $257K | ﹤0.01% |
175,000
| – | – |
|
654
Coterra Energy
CTRA
$18.6B
| $257K | ﹤0.01% |
10,000
-1,839
| -16% | -$47.3K |
|
655
Tyler Technologies
TYL
$24B
| $257K | ﹤0.01% |
775
-616
| -44% | -$204K |
|
656
United-Guardian
UG
$37.7M
| $255K | ﹤0.01% |
17,062
| – | – |
|
657
Consolidated Edison
ED
$35.2B
| $253K | ﹤0.01% |
2,661
-448
| -14% | -$42.6K |
|
658
Ford
F
$46.8B
| $253K | ﹤0.01% |
22,796
+2,350
| +11% | +$26.1K |
|
|
ALEX
659
Alexander & Baldwin
ALEX
$1.37B
| $251K | ﹤0.01% |
14,008
-18,461
| -57% | -$331K |
|
660
Freeport-McMoran
FCX
$65.9B
| $251K | ﹤0.01% |
8,600
| – | – |
|
661
Credit Acceptance
CACC
$5.9B
| $248K | ﹤0.01% |
525
| – | – |
|
662
SPDR Dow Jones Industrial Average ETF Trust
DIA
$39.7B
| $246K | ﹤0.01% |
800
| – | – |
|
663
Pentair
PNR
$18.5B
| $246K | ﹤0.01% |
5,385
-1,434
| -21% | -$65.5K |
|
664
Novo Nordisk
NVO
$241B
| $243K | ﹤0.01% |
4,378
| – | – |
|
665
Invesco Dividend Achievers ETF
PFM
$737M
| $243K | ﹤0.01% |
7,050
| – | – |
|
666
Morningstar
MORN
$10.8B
| $240K | ﹤0.01% |
993
| – | – |
|
667
NOV
NOV
$4.94B
| $239K | ﹤0.01% |
14,187
| – | – |
|
668
Fiserv
FI
$73.8B
| $238K | ﹤0.01% |
2,680
-800
| -23% | -$71K |
|
669
Scotiabank
BNS
$79.9B
| $236K | ﹤0.01% |
4,000
| – | – |
|
670
OP Bancorp
OPBK
$218M
| $236K | ﹤0.01% |
22,500
| – | – |
|
671
Tandem Diabetes Care
TNDM
$864M
| $236K | ﹤0.01% |
4,000
| – | – |
|
672
Cooper Companies
COO
$13.6B
| $234K | ﹤0.01% |
3,000
| – | – |
|
673
Exelon
EXC
$43.9B
| $234K | ﹤0.01% |
5,180
| – | – |
|
674
Vanguard International Dividend Appreciation ETF
VIGI
$8.55B
| $231K | ﹤0.01% |
3,375
+1,100
| +48% | +$75.3K |
|
675
D.R. Horton
DHI
$54B
| $230K | ﹤0.01% |
3,478
| – | – |
|